Drugmakers receive FDA warning letter for cGMP violations, failure to obtain IND approval
Regulatory NewsFerdous Al-Faruque
GMPPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueGMPPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)